Literature DB >> 20940727

Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice.

Jugta Khuman1, William P Meehan, Xiaoxia Zhu, Jianhua Qiu, Ulrike Hoffmann, Jimmy Zhang, Eric Giovannone, Eng H Lo, Michael J Whalen.   

Abstract

Tumor necrosis factor alpha (TNFα) and Fas receptor contribute to cell death and cognitive dysfunction after focal traumatic brain injury (TBI). We examined the role of TNFα/Fas in postinjury functional outcome independent of cell death in a novel closed head injury (CHI) model produced with weight drop and free rotational head movement in the anterior-posterior plane. The CHI produced no cerebral edema or blood-brain barrier damage at 24 to 48 hours, no detectable cell death, occasional axonal injury (24 hours), and no brain atrophy or hippocampal cell loss (day 60). Microglia and astrocytes were activated (48 to 72 hours). Tumor necrosis factor-α mRNA, Fas mRNA, and TNFα protein were increased in the brain at 3 to 6 hours after injury (P<0.001 versus sham injured). In wild-type (WT) mice, CHI produced hidden platform (P=0.009) and probe deficits (P=0.001) in the Morris water maze versus sham. Surprisingly, injured TNFα/Fas knockout (KO) mice performed worse in hidden platform trials (P=0.036) but better in probe trials than did WT mice (P=0.0001). Administration of recombinant TNFα to injured TNFα/Fas KO mice reduced probe trial performance to that of WT. Thus, TNFα/Fas influence cognitive deficits independent of cell death after CHI. Therapies targeting TNFα/Fas together may be inappropriate for patients with concussive TBI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940727      PMCID: PMC3049532          DOI: 10.1038/jcbfm.2010.172

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  37 in total

1.  Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment.

Authors:  S M Knoblach; L Fan; A I Faden
Journal:  J Neuroimmunol       Date:  1999-03-01       Impact factor: 3.478

2.  TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice.

Authors:  Daniela Bermpohl; Zerong You; Eng H Lo; Hyung-Hwan Kim; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-04       Impact factor: 6.200

3.  Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury.

Authors:  U Scherbel; R Raghupathi; M Nakamura; K E Saatman; J Q Trojanowski; E Neugebauer; M W Marino; T K McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

4.  A concussive-like brain injury model in mice (I): impairment in learning and memory.

Authors:  Y P Tang; Y Noda; T Hasegawa; T Nabeshima
Journal:  J Neurotrauma       Date:  1997-11       Impact factor: 5.269

5.  Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: relationship with neuronal cell death and inflammatory mediators.

Authors:  M B Grosjean; P M Lenzlinger; P F Stahel; I Yatsiv; E Shohami; O Trentz; T Kossmann; M C Morganti-Kossmann
Journal:  Histol Histopathol       Date:  2007-03       Impact factor: 2.303

6.  Acute plasmalemma permeability and protracted clearance of injured cells after controlled cortical impact in mice.

Authors:  Michael J Whalen; Turgay Dalkara; Zerong You; Jianhua Qiu; Daniela Bermpohl; Niyati Mehta; Bernhard Suter; Pradeep G Bhide; Eng H Lo; Maria Ericsson; Michael A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-22       Impact factor: 6.200

Review 7.  Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation.

Authors:  D Arciniegas; L Adler; J Topkoff; E Cawthra; C M Filley; M Reite
Journal:  Brain Inj       Date:  1999-01       Impact factor: 2.311

8.  Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury.

Authors:  E Shohami; R Bass; D Wallach; A Yamin; R Gallily
Journal:  J Cereb Blood Flow Metab       Date:  1996-05       Impact factor: 6.200

9.  Mechanoporation induced by diffuse traumatic brain injury: an irreversible or reversible response to injury?

Authors:  Orsolya Farkas; Jonathan Lifshitz; John T Povlishock
Journal:  J Neurosci       Date:  2006-03-22       Impact factor: 6.167

10.  Spatiotemporal pattern of neuroinflammation after impact-acceleration closed head injury in the rat.

Authors:  Servan Rooker; Sebastian Jander; Jos Van Reempts; Guido Stoll; Philippe G Jorens; Marcel Borgers; Jan Verlooy
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

View more
  42 in total

1.  Combination therapy targeting Akt and mammalian target of rapamycin improves functional outcome after controlled cortical impact in mice.

Authors:  Juyeon Park; Jimmy Zhang; Jianhua Qiu; Xiaoxia Zhu; Alexei Degterev; Eng H Lo; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-21       Impact factor: 6.200

2.  Controlled cortical impact before or after fear conditioning does not affect fear extinction in mice.

Authors:  Demetrio Sierra-Mercado; Lauren M McAllister; Christopher C H Lee; Mohammed R Milad; Emad N Eskandar; Michael J Whalen
Journal:  Brain Res       Date:  2015-02-23       Impact factor: 3.252

3.  Decreased microvascular cerebral blood flow assessed by diffuse correlation spectroscopy after repetitive concussions in mice.

Authors:  Erin M Buckley; Benjamin F Miller; Julianne M Golinski; Homa Sadeghian; Lauren M McAllister; Mark Vangel; Cenk Ayata; William P Meehan; Maria Angela Franceschini; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-08       Impact factor: 6.200

4.  Low-level laser therapy effectively prevents secondary brain injury induced by immediate early responsive gene X-1 deficiency.

Authors:  Qi Zhang; Chang Zhou; Michael R Hamblin; Mei X Wu
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-21       Impact factor: 6.200

5.  Increasing recovery time between injuries improves cognitive outcome after repetitive mild concussive brain injuries in mice.

Authors:  William P Meehan; Jimmy Zhang; Rebekah Mannix; Michael J Whalen
Journal:  Neurosurgery       Date:  2012-10       Impact factor: 4.654

6.  Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice.

Authors:  Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2014-08-15       Impact factor: 5.269

Review 7.  Experimental Designs for Repeated Mild Traumatic Brain Injury: Challenges and Considerations.

Authors:  Amanda N Bolton-Hall; W Brad Hubbard; Kathryn E Saatman
Journal:  J Neurotrauma       Date:  2018-11-22       Impact factor: 5.269

8.  Role of Akt and mammalian target of rapamycin in functional outcome after concussive brain injury in mice.

Authors:  Xiaoxia Zhu; Juyeon Park; Julianne Golinski; Jianhua Qiu; Jugta Khuman; Christopher C H Lee; Eng H Lo; Alexei Degterev; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-18       Impact factor: 6.200

9.  Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder.

Authors:  Jose J Miguel-Hidalgo; Angela Whittom; Ashley Villarreal; Madhav Soni; Ashish Meshram; Jason C Pickett; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Affect Disord       Date:  2014-02-10       Impact factor: 4.839

10.  Concussive injury before or after controlled cortical impact exacerbates histopathology and functional outcome in a mixed traumatic brain injury model in mice.

Authors:  Heda R Dapul; Juyeon Park; Jimmy Zhang; Christopher Lee; Ali DanEshmand; Josephine Lok; Cenk Ayata; Tory Gray; Allison Scalzo; Jianhua Qiu; Eng H Lo; Michael J Whalen
Journal:  J Neurotrauma       Date:  2013-02-20       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.